Giuliano Perfetti

Jubilant Biosys Expanded capabilities of Facilities for Discovery Chemistry and In-Vitro ADME Service

Jubilant Biosys provides services for Turning Point Therapeutics Inc. for multiple small molecule oncology research programs. Turning Point is a precision oncology company developing next-generation therapies that target genetic drivers of cancer.